Mechanism of Obstruction-Induced AKI

Obstruction of the urinary tract causes renal injury through several interconnected mechanisms:

1. Increased intraluminal pressure → retrograde transmission to Bowman’s capsule → reduces GFR
2. Vasoconstriction → increased renal vascular resistance (initially mediated by prostaglandins/NO, then RAS activation)
3. Tubular dysfunction → altered reabsorption and secretion
4. Interstitial edema and inflammation → ongoing fibrosis if obstruction persists
5. Activation of complement and cytokine cascade → sterile inflammation

Timeline: Acute obstruction typically causes measurable GFR decline within hours. Pressure normalization is rapid after relief (minutes to hours), but functional recovery may lag by days to weeks.

Acute vs. Chronic Obstruction

Clinical Pearl: Do not equate hydronephrosis with acute obstruction. Chronic high-grade obstruction can exist without dilated collecting system.

Unilateral vs. Bilateral Obstruction

• Unilateral obstruction → usually does NOT cause AKI (compensatory hyperfiltration of contralateral kidney)
• Bilateral obstruction → causes AKI (both kidneys affected) or AKI in solitary kidney (functional obstruction in single functional unit)
• Clinical implication: Absence of AKI does not rule out unilateral obstruction; serial creatinine may appear stable while renal function is actually declining

Complete vs. Partial Obstruction

• Complete obstruction → anuria or severe oliguria, rapid Cr rise
• Partial obstruction → may present with minimal Cr elevation, preserved urine output
  • Danger: Partial obstruction is easily missed on clinical grounds alone
  • Progressive slow obstruction (e.g., malignancy, strictures) may not trigger alarm until advanced

Post-Obstructive Diuresis: Mechanism and Management

Definition: Excessive urine output (often >200 mL/h) following relief of obstruction.

Diagnostic Accuracy

Take-home: A negative US does NOT exclude obstruction.

What Ultrasound Does Well

1. Assesses kidney size and echogenicity
   • Enlarged hyperechoic kidney suggests ATN or glomerulonephritis
   • Shrunken kidney suggests chronic kidney disease
2. Grades hydronephrosis severity (subjective but clinically useful)
   • Grade 0: No hydronephrosis
   • Grade 1 (mild): Separation of renal sinus echoes only; no pelvic dilatation
   • Grade 2 (moderate): Pelvic dilatation; calyces dilated but maintaining convexity
   • Grade 3 (severe): Major calyces dilated and blunted; renal parenchyma compressed
3. Bladder assessment
   • Post-void residual volume (PVR) suggests lower urinary tract obstruction
   • Bladder wall thickening indicates chronic outlet obstruction
4. Assesses for perinephric fluid (suggests rupture of fornix)

What Ultrasound Misses

Resistive Index (RI)

Definition: RI = (Peak systolic velocity − End diastolic velocity) / Peak systolic velocity

Values: - Normal RI: <0.60 (varies by age; increases slightly with age) - RI >0.70: Suggests intrinsic renal disease or obstruction - RI >0.80: Highly suspicious for obstruction

Utility and limitations: - Sensitivity for obstruction: 60–70% - Specificity: 70–80% - Confounders: - Elevated RI in acute tubular necrosis (acute injury without obstruction) - Elevated RI in chronic kidney disease (fibrosis) - Elevated RI in advanced age (vascular stiffness) - Elevation in systemic hypertension (vascular resistance) - Clinical bottom line: RI is suggestive but not diagnostic; use as adjunct to morphologic findings

CT Without Contrast (Best for Stones)

Sensitivity: 91–97% for nephrolithiasis Specificity: 91–100% Advantages: - Gold standard for stone detection (95% of stones opaque) - Identifies stone location, size, density - Can estimate stone composition by Hounsfield units (HU): - Calcium oxalate/phosphate: 500–3000 HU - Uric acid: 200–400 HU - Cystine: 600–1100 HU - Drug crystals (indinavir, sulfadiazine): 100–200 HU

Radiation exposure: 5–10 mSv (equivalent to ~3 years background radiation)

When mandatory: - Suspicion of stone obstruction - US equivocal or negative with high pretest probability - Single kidney with anuria - Recurrent stone formers

CT With IV Contrast (For Masses, Soft Tissue)

Advantages: - Superior for malignant obstruction (tumors, nodes) - Excellent for retroperitoneal fibrosis (periaortic soft tissue enhancement) - Identifies ureteral injuries, strictures - Opacifies collecting system and ureters - Can assess degree of renal perfusion

Disadvantages: - Contrast-induced nephropathy (CIN) risk - Adds ~10 mL iodinated contrast to imaging

Use in AKI: - Baseline creatinine <1.5 mg/dL: Safe; prophylaxis usually not needed - Creatinine 1.5–3.0 mg/dL: Use iso-osmolar or low-osmolar contrast; hydrate IV - Creatinine >3.0 or on dialysis: Discuss with radiology; often proceed with careful hydration; risk of CIN is lower than risk of missing diagnosis - Diabetes + CKD: Higher CIN risk; consider metformin washout, hydration

Typical contrast volume: 50–120 mL iodinated contrast

Head-to-Head Comparison Table

Clinical Role

Diuretic renography determines functional significance of obstruction in equivocal cases where anatomic findings (hydronephrosis) are present but obstruction is uncertain (e.g., dilated non-obstructed collecting system, UPJ obstruction, post-surgical follow-up).

Imaging Agent and Protocol

Most common agent: Tc-99m MAG3 (mercaptoacetyltriglycine) - Agent is filtered and secreted by proximal tubule - Parallels effective renal plasma flow - Superior to DTPA in renal insufficiency (DTPA filtered only; accuracy declines if GFR <30)

Less common: Tc-99m DTPA (diethylenetriaminepentaacetic acid) - Filtered by glomerulus only - Still acceptable; easier availability

Protocol: 1. Inject agent IV; begin imaging (typically anterior pelvic view) 2. Allow 20–30 min for agent uptake and excretion into collecting system 3. At peak filling, administer furosemide 0.5–1.0 mg/kg IV (typical dose 20–40 mg) 4. Continue imaging for another 20–30 min post-diuretic 5. Generate renogram curve showing activity over time in kidney/pelvis and bladder

Interpretation

Normal renogram pattern: - Rapid uptake (seconds) - Peak activity at 3–5 min - Rapid washout after furosemide (T½ <10 min = half-time to clear 50% of peak activity) - Curve returns to baseline by 20 min

Dilatation categories: 1. Non-obstructed dilated collecting system (“dilated non-obstructed” or DNU) - Pelvicalyceal dilatation present on imaging - Rapid washout after diuretic (T½ <10 min) - Curve normalizes quickly - Mechanism: Capacious collecting system; not obstruction-induced but responds to diuretic

2. Indeterminate pattern
   • T½ 10–20 min
   • Curve plateaus but may slowly decline with prolonged imaging
   • Clinical significance: Gray zone; functional significance unclear
   • Management: Consider delayed imaging, clinical context, repeat testing
3. Obstructed pattern
   • T½ >20 min
   • Curve continues rising or plateaus despite furosemide
   • No washout; activity persists in pelvis at 30 min
   • Mechanism: Anatomic or functional obstruction impeding urine flow

Split Renal Function Assessment

Renography provides differential renal function (DRF): - Percentage contribution of each kidney to total GFR - Normal: Each kidney ~50%; asymmetry <10% considered normal

Clinical use: - If obstructed kidney has DRF <15%, interventional risk-benefit shifts toward observation - If DRF >20%, intervention more likely to benefit function - If DRF <10%, prognosis for recovery poor; palliative approach justified

Limitations and Pitfalls

1. Dehydration: Reduces urine output; poor tracer delivery; false-positive obstruction pattern
   • Mitigation: Ensure adequate IV hydration before test (250–500 mL NS)
2. Poor renal function (GFR <30):
   • DTPA becomes inaccurate (filtered only; poor clearance)
   • MAG3 preferred (secreted)
   • Even with MAG3, functional reserve minimal; curve interpretation difficult
3. Bladder outlet obstruction/high post-void residual:
   • High intravesical pressure mimics upper tract obstruction
   • Catheterization or aggressive voiding may be needed
4. Hyperactivity in kidney from previous imaging with Tc-99m agents within 24h
   • Request scheduling >24h apart if possible
5. Technical limitations:
   • Cannot visualize ureters well (activity washes out too quickly)
   • Limited anatomic detail (unlike CT/US)

When to Order

• Chronic hydronephrosis with uncertain obstruction: Determine if truly obstructed or dilated non-obstructed
• Unilateral hydronephrosis in pregnancy: Differentiate physiologic from obstructive
• UPJ/UVJ obstruction evaluation: Quantify degree of obstruction; guide surgical decision-making
• Recurrent pyelonephritis with hydronephrosis: Assess if obstruction contributing
• Post-surgical follow-up: Serial assessment of split function and obstruction resolution

Avoid ordering: - Acute stone with normal renal function (diagnosis clear; focus on treatment) - Obvious bilateral obstruction (act first, no time for functional study) - Solitary obstructed kidney with anuria (intervention indicated regardless of function)

Evidence Base

Reference: Society of Nuclear Medicine and Molecular Imaging (SNMMI) and European Association of Nuclear Medicine (EANM) Practice Guideline for Diuretic Renal Scintigraphy (2018)

Epidemiology and Presentation

• Incidence: 0.3–1 per 100,000 (rare but underdiagnosed)
• Males >> Females (3:1)
• Peak age: 50–70 years

Pathophysiology

Idiopathic RF is mediated by IgG4-positive plasma cells in ~2/3 of cases (IgG4-related disease). Fibroblasts and myofibroblasts proliferate, encasing retroperitoneal structures (aorta, ureters, IVC, nerves).

Imaging Presentation

Ultrasound: Often normal or shows hydronephrosis without obvious cause - May see periaortic echogenicity, but difficult to characterize

CT findings: - Pathognomonic: Periaortic (or paracaval) soft tissue mass - Encases aorta (“aortic-hugging” appearance) - Often bilateral ureteric involvement - Smooth, tapering ureteral narrowing - Medial displacement of ureters (fibrous tissue pulls ureters medially—diagnostic clue) - Contrast enhancement: Tissue enhances less than muscle - Calcification: Rare (unlike malignancy) - Relative sparing of kidneys unless advanced hydronephrosis

Clinical Presentation in AKI Context

• Bilateral hydronephrosis with preserved renal size (no mass, no stone)
• Elevated inflammatory markers: ESR often >100 mm/h, elevated CRP
• Constitutional symptoms: Dull flank/back pain, low-grade fever, malaise
• No fever or dysuria (not infection)
• May have systemic IgG4 involvement (pancreatitis, sialadenitis, thyroid)

Differential Diagnosis

Management Approach

1. Confirm diagnosis: CT ± IgG4 testing, ESR/CRP, consider biopsy if atypical
2. Assess disease activity: Inflammatory markers; imaging follow-up
3. Initiate immunosuppression (if confirmed IgG4-RF):
   • Corticosteroids: Prednisone 1 mg/kg/day × 4 weeks, then taper
   • Response in 50–70%
   • Add azathioprine, mycophenolate, or rituximab if inadequate response
4. Manage obstruction:
   • If severe AKI or anuria: ureteral stent or percutaneous nephrostomy
   • Most improve with medical therapy; stents often can be removed within 3–6 months

Deciding When to Intervene Emergently

Absolute indications for immediate intervention (within hours):

Relative indications (consider in context of renal function trajectory):

Intervention Modalities

Post-Intervention Monitoring

First 24 hours: - Assess urine output q1–2h (expect increased urine flow) - Check electrolytes q6h - Monitor temperature (assess for fever from pyelonephritis) - Check creatinine at 24h

Ongoing (days 2–7): - Serum creatinine daily until stable - Electrolytes daily - Urine output daily - Assess post-void residual (if stent placed) at 24–48h

Key endpoints: - Creatinine decline/stabilization (expect 10–20% daily improvement if no other renal disease) - Resolution of post-obstructive diuresis (output normalizes) - Electrolytes normalized - Patient afebrile, hemodynamically stable

Specific Scenarios

Acute stone obstruction
   ↓
US or CT confirms stone + obstruction
   ↓
Assess: Cr, fever, sepsis, UOP, pain
   ↓
   ├─ Afebrile, no sepsis, normal/mildly elevated Cr, nonoliguric
   │  → Expectant management (hydration, pain control) + monitoring
   │     Intervention if: Cr rises >25% from baseline, UOP declines, fever develops
   │
   └─ Fever, sepsis, or rapidly rising Cr, anuria
      → Emergent intervention (stent or PCN)

Neurogenic Bladder and Outlet Obstruction

Mechanism: Impaired bladder emptying → elevated intravesical pressure → retrograde transmission to kidneys

Common causes: Spinal cord injury, multiple sclerosis, Parkinson’s disease, diabetes (neurogenic complications)

Imaging findings: - Bilateral hydronephrosis (may be non-dilated if fibrosis) - Thick-walled bladder - Elevated post-void residual (>50 mL pathologic)

Management: - Clean intermittent self-catheterization (CISC) most important intervention - Anticholinergics (oxybutynin) to reduce detrusor hyperreflexia - Prophylactic antibiotics (long-term colonization near-universal) - Monitor renal function annually; imaging as needed

Benign Prostatic Hyperplasia (BPH) and Urethral Stricture

BPH-induced obstruction: - More common in elderly men - Insidious onset; gradual creatinine decline may not trigger concern - Reduced stream, nocturia, incomplete emptying

Diagnosis: - Elevated PVR on US - Cystoscopy shows enlarged prostate (not needed for diagnosis in AKI workup)

Management: Alpha-blocker (tamsulosin, doxazosin) ± 5-alpha reductase inhibitor (finasteride) - If inadequate response: transurethral resection of prostate (TURP)

Urethral stricture: - Etiology: prior trauma, instrumentation, lichen sclerosus, gonococcal urethritis - Diagnosis: retrograde urethrography or cystoscopy - Management: direct visual internal urethrotomy (DVIU) or urethroplasty

Pelvic Malignancy

Cancers causing obstruction: Prostate, bladder, colorectal, ovarian, uterine

Imaging findings vary by tumor type but may include: - Mass encasing ureter - Lymphadenopathy compressing ureter - Bladder wall infiltration - Unilateral or bilateral obstruction

Considerations: - Prior oncologic history (recurrence vs. new primary) - Extent of disease (CT staging) - Prognosis (inform intervention decision)

Vignette 1: Acute Stone Obstruction in Nonoliguric Patient

Presentation: 68-year-old man with history of recurrent kidney stones presents with right flank pain × 6 hours. Creatinine 1.1 (baseline 0.9), urine output 1.5 L in 6 hours. Afebrile, hemodynamically stable.

Imaging: US shows right hydronephrosis grade 2; no left-sided findings.

Decision: - Unilateral obstruction → no AKI (contralateral kidney is functioning) - Afebrile, nonoliguric, minimal Cr elevation - Management: Expectant; hydrate, pain control, monitor Cr daily, check UOP - Intervention threshold: If Cr rises >25% from baseline OR urine output declines OR fever develops

Expected course: Stone passes within 2–4 weeks; Cr returns to baseline; no intervention needed

Vignette 2: Bilateral Obstruction with Sepsis

Presentation: 52-year-old woman with history of recurrent strictures (prior ureteral surgery) presents with fever (39.2°C), flank pain, and nausea × 24 hours. Creatinine 2.8 (baseline 1.1), oliguria (UOP 400 mL/24h), WBC 14,000, lactate 2.5.

Imaging: US shows bilateral hydronephrosis grade 3; bladder normal.

Decision: - Bilateral obstruction + sepsis = LIFE-THREATENING - Immediate action: 1. Broad-spectrum antibiotics (meropenem + vancomycin until culture results) 2. Fluid resuscitation 3. Emergent bilateral PCN placement (or stent if immediate cystoscopy available)

Expected course: Fever resolves within 24–48h of decompression; creatinine declines over next 3–5 days; source identified (stricture documented on antegrade imaging); definitive management (redo ureteral surgery, stent exchange) planned once stable

Vignette 3: Bilateral Hydronephrosis, No Obstruction on Imaging

Presentation: 71-year-old man with prostate cancer (metastatic to bone) presents with creatinine elevation (2.2, baseline 1.0). Imaging shows bilateral hydronephrosis. CT with contrast shows NO mass, NO nodes, NO stone, but periaortic soft tissue prominence.

Labs: ESR 102, CRP 8.5, IgG4 elevated (95 mg/dL; normal <135 but suspicious)

Decision: - Suspect retroperitoneal fibrosis (IgG4-related disease) - Confirmatory steps: 1. Consider biopsy (periaortic tissue) if diagnosis uncertain 2. Check systemic IgG4 involvement (pancreas, salivary glands) 3. Rheumatology/pathology consultation - Initial management: 1. Place ureteral stent(s) or PCN for acute decompression 2. Start corticosteroids (prednisone 1 mg/kg/day) 3. Plan repeat imaging in 4–6 weeks to assess response

Expected course: With steroid therapy, 50–70% show significant improvement in obstruction within 3–6 months; stents can often be removed; long-term remission possible with immunosuppression

Vignette 4: Non-Dilated Obstructive Uropathy

Presentation: 44-year-old woman with anuria × 2 hours post-cesarean delivery for preeclampsia. Creatinine 1.8 (pre-delivery 0.7). US: normal kidneys, no hydronephrosis, normal bladder.

Clinical context: Intra-operative note mentions possible ureteral injury.

Decision: - NDOU suspected (acute ureteral injury, insufficient time for hydronephrosis to develop) - Imaging: Non-contrast CT abdomen/pelvis → shows urinoma, ureteral extravasation - Management: 1. Emergent urology/surgery consultation 2. PCN placement for drainage 3. Surgical re-exploration ± ureteral repair depending on delay and degree of injury